Search

Learn how GSK graduate Dr. Ellen Horste’s time investigating fundamental biological questions prepared her for a career in the emerging field of gene therapy.

… Friday, July 12, 2024 Ellen Horste’s job is a little bit like packing for Mars — where every efficiency and every little bit of room that can be saved matter. As a payload engineer for a gene therapy startup, Dr. Horste designs genetic elements that get loaded into a virus for delivery into the human

Learn more about five essential strategies for coping with the fear of cancer, from MSK psychiatrist Dr. Monique James.

… Thursday, November 20, 2025 There’s no doubt about it: Cancer is scary. But the fear of cancer, sometimes called “carcinophobia,” can cause significant distress. You may be afraid of developing cancer. You may have just been diagnosed. In either case, it’s important to remember that there are ongoing

Learn the differences between physician assistants and nurse practitioners and the important roles they play at Memorial Sloan Kettering.

… Monday, July 6, 2020 At Memorial Sloan Kettering, teamwork is the name of the game. It’s not just one professional taking care of a patient; care teams ensure that every person who walks through the doors is provided for and supported. Vital members of a patient’s care team include physician assistants

An international, multi-center study has revealed the discovery of a novel oncogene that is associated with uveal melanoma, the most common form of eye cancer. Researchers have isolated an oncogene called GNA11 and have found that it is present in more than 40 percent of tumor samples taken from patients with uveal melanoma.

… Wednesday, November 17, 2010 An international, multi-center study has revealed the discovery of a novel oncogene that is associated with uveal melanoma , the most common form of eye cancer. Researchers have isolated an oncogene called GNA11 and have found that it is present in more than 40 percent of

Learn more about entrectinib, a targeted therapy being evaluated in patients with solid tumors.

… Wednesday, April 5, 2017 Summary Entrectinib is a targeted therapy that passed safety and tolerability standards in patients with solid tumors in two phase I trials. Now, the drug will be tested in a phase II trial. At last year’s annual meeting of the American Association for Cancer Research (AACR),

Researchers have shown how CH, a blood condition related to aging, affects cancer outcomes — through a phenomenon called tumor-infiltrating clonal hematopoiesis.

… Thursday, April 24, 2025 Doctors and scientists have known for nearly a decade that a precancerous blood condition called  clonal hematopoiesis (CH) is present in one in three patients with solid tumors and is associated with poor cancer outcomes. People with CH are less likely to respond to treatment

DNA in the mitochondria of cancer cells may yield insights that lead to more accurate prognoses and new treatment strategies.

… Friday, April 23, 2021 Most human DNA is packaged in the chromosomes within a cell’s nucleus. But our cells also have what is called mitochondrial DNA (mtDNA). The mitochondria are small structures located in the fluid surrounding the nucleus that help cells produce energy from nutrients. Scientists

A new laboratory study from MSK is shedding light on the mechanisms by which high fructose consumption early in life may directly impact brain development and increase the risk of anxiety disorders later on.

… Wednesday, June 11, 2025 Diets high in fructose have been under the microscope for their contribution to increasing rates of obesity, diabetes, and other metabolic diseases. Recent evidence suggests the negative effects may also extend to mood and anxiety disorders,  especially in adolescents . Now,

Researchers from Memorial Sloan Kettering Cancer Center (MSK) shared new data from a survey of members of the Society of Gynecologic Oncology (SGO) showing that sexual harassment and observed gender discrimination continue to be significant issues in the medical community. The results of the study found that more than 60 percent of gynecologic oncologists had experienced sexual harassment, while only 10 percent of survey respondents reported the incident. The findings were presented as part of the press program for this year’s annual meeting of the American Society of Clinical Oncology (ASCO).

… Monday, June 3, 2019 Marina Stasenko, MD Marina Stasenko, MD Researchers from Memorial Sloan Kettering Cancer Center (MSK) shared new data from a survey of members of the Society of Gynecologic Oncology (SGO) showing that sexual harassment and observed gender discrimination continue to be significant

The Lisa and Scott Stuart Center for Adolescent and Young Adult Cancers will revolutionize cancer treatment for people ages 15 to 39.

… Tuesday, September 21, 2021 While overall cancer cases are declining, they are on the rise in older adolescents and young adults. Today, Memorial Sloan Kettering Cancer Center (MSK) announces the establishment of the Lisa and Scott Stuart Center for Adolescent and Young Adult Cancers (the Stuart Center